Nursing and Health Professions
Lung Cancer
100%
Second Cancer
100%
Confidence Interval
75%
Standardized Incidence Ratio
75%
Protein Tyrosine Kinase Inhibitor
37%
Cohort Analysis
25%
Malignant Neoplasm
25%
National Health Insurance
12%
Population
12%
Cancer Incidence
12%
Lung Adenocarcinoma
12%
Epidermal Growth Factor Receptor
12%
Medicine and Dentistry
Lung Cancer
100%
Second Cancer
100%
Standardized Incidence Ratio
75%
Tyrosine-Kinase Inhibitor
37%
Malignant Neoplasm
25%
Cohort Analysis
25%
Population
12%
Bone Tissue
12%
Smoking
12%
Epidermal Growth Factor Receptor
12%
Neck
12%
Cancer Risk
12%
Lung Adenocarcinoma
12%
Thyroid Gland
12%
Cancer Incidence
12%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Second Cancer
100%
Standardized Incidence Ratio
75%
Protein Tyrosine Kinase Inhibitor
37%
Malignant Neoplasm
25%
Cohort Study
25%
Cancer Incidence
12%
Lung Adenocarcinoma
12%
Epidermal Growth Factor Receptor
12%
Biochemistry, Genetics and Molecular Biology
Standardized Incidence Ratio
100%
Tyrosine Kinase Inhibitor
50%
Cohort Study
33%
Cancer Incidence
16%
Smoking
16%
Population
16%
Epidermal Growth Factor Receptor
16%